WASHINGTON, Jan. 30, 2018 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will
release results for the fourth quarter and full year 2017 on
Wednesday, February 14, 2018, after
the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, February 14, 2018, during which
management will discuss the fourth quarter and full year 2017
financial results and other corporate activities. To participate in
the conference call, please dial 1-888-771-4371 (domestic) or
1-847-585-4405 (international) and use passcode 46291578.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Wednesday, February 14, 2018, beginning at
7:00 PM ET and will be accessible
until Wednesday, February 21, 2018,
at 11:59 PM ET. The replay call-in
number is 1-888-843-7419 for domestic callers and 1-630-652-3042
for international callers. The passcode number is
46291578.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global
biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Jim
Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2017-financial-results-on-february-14-2018-300590562.html
SOURCE Vanda Pharmaceuticals Inc.